Sant Chawla, M.D., FRACP

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Advenchen Laboratories
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bayer
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Inhibrx
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    NKMax
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Thyme
    Topic:
    Speakers Bureau
    Date added:
    09/26/2024
    Date updated:
    09/26/2024

Pages

Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies